Wealthcare Advisory Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,050
Closed -$8K 333
2020
Q1
$8K Buy
+3,050
New +$8K ﹤0.01% 964